Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Pharmacoproteomics Profile in Response to Acamprosate Treatment of an Alcoholism Animal Model.

Germany CE, Reker AN, Hinton DJ, Oliveros A, Shen X, Andres-Beck LG, Wininger KM, Trutschl M, Cvek U, Choi DS, Nam HW.

Proteomics. 2018 Apr;18(7):e1700417. doi: 10.1002/pmic.201700417.

PMID:
29437267
2.

Tranexamic Acid: Promise or Panacea: The Impact of Air Medical Administration of Tranexamic Acid on Morbidity, Mortality, and Length of Stay.

Cornelius BG, McCarty K, Hylan K, Cornelius A, Carter K, Smith KWG, Ristic S, Vining D, Cvek U, Trutschl M.

Adv Emerg Nurs J. 2018 Jan/Mar;40(1):27-35. doi: 10.1097/TME.0000000000000175.

PMID:
29384773
3.

Two year follow-up of Crohn's patients substituted to certolizumab anti-TNFa therapy: SAVANT 2.

Motlis A, Boktor M, Jordan P, Cvek U, Trutschl M, Alexander JS.

Pathophysiology. 2017 Dec;24(4):291-295. doi: 10.1016/j.pathophys.2017.07.004. Epub 2017 Aug 9.

PMID:
28818362
4.

Substitution with Alternative Anti-TNF╬▒ Therapy (SAVANT)-Outcomes of a Crohn's Disease Cohort Undergoing Substitution Therapy with Certolizumab.

Boktor M, Motlis A, Aravantagi A, Sheth A, Jordan P, Morris J, Manas K, Hussain N, Cvek U, Trutschl M, Becker F, Alexander JS.

Inflamm Bowel Dis. 2016 Jun;22(6):1353-61. doi: 10.1097/MIB.0000000000000765.

PMID:
27104819
5.

Gastric cancer in women: A regional health-center seven year retrospective study.

Suryawala K, Soliman D, Mutyala M, Nageeb S, Boktor M, Seth A, Aravantagi A, Sheth A, Morris J, Jordan P, Manas K, Cvek U, Trutschl M, Becker F, Alexander J.

World J Gastroenterol. 2015 Jul 7;21(25):7805-13. doi: 10.3748/wjg.v21.i25.7805.

6.

Both MC1 and MC3 Receptors Provide Protection From Cerebral Ischemia-Reperfusion-Induced Neutrophil Recruitment.

Holloway PM, Durrenberger PF, Trutschl M, Cvek U, Cooper D, Orr AW, Perretti M, Getting SJ, Gavins FN.

Arterioscler Thromb Vasc Biol. 2015 Sep;35(9):1936-44. doi: 10.1161/ATVBAHA.115.305348. Epub 2015 Jun 25.

7.

Blood circulating microparticle species in relapsing-remitting and secondary progressive multiple sclerosis. A case-control, cross sectional study with conventional MRI and advanced iron content imaging outcomes.

Alexander JS, Chervenak R, Weinstock-Guttman B, Tsunoda I, Ramanathan M, Martinez N, Omura S, Sato F, Chaitanya GV, Minagar A, McGee J, Jennings MH, Monceaux C, Becker F, Cvek U, Trutschl M, Zivadinov R.

J Neurol Sci. 2015 Aug 15;355(1-2):84-9. doi: 10.1016/j.jns.2015.05.027. Epub 2015 May 28.

8.

Genome-wide DNA methylation as an epigenetic consequence of Epstein-Barr virus infection of immortalized keratinocytes.

Birdwell CE, Queen KJ, Kilgore PC, Rollyson P, Trutschl M, Cvek U, Scott RS.

J Virol. 2014 Oct;88(19):11442-58. doi: 10.1128/JVI.00972-14. Epub 2014 Jul 23.

9.

Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis.

Omura S, Kawai E, Sato F, Martinez NE, Chaitanya GV, Rollyson PA, Cvek U, Trutschl M, Alexander JS, Tsunoda I.

Circ Cardiovasc Genet. 2014 Aug;7(4):444-54. doi: 10.1161/CIRCGENETICS.114.000505. Epub 2014 Jul 16.

10.

Epstein-Barr virus-induced epigenetic alterations following transient infection.

Queen KJ, Shi M, Zhang F, Cvek U, Scott RS.

Int J Cancer. 2013 May 1;132(9):2076-86. doi: 10.1002/ijc.27893. Epub 2012 Nov 2.

11.

Identification of genes correlated with early-stage bladder cancer progression.

Stone R 2nd, Sabichi AL, Gill J, Lee IL, Adegboyega P, Dai MS, Loganantharaj R, Trutschl M, Cvek U, Clifford JL.

Cancer Prev Res (Phila). 2010 Jun;3(6):776-86. doi: 10.1158/1940-6207.CAPR-09-0189. Epub 2010 May 25.

12.

Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion.

Cheepala SB, Yin W, Syed Z, Gill JN, McMillian A, Kleiner HE, Lynch M, Loganantharaj R, Trutschl M, Cvek U, Clifford JL.

Mol Cancer. 2009 May 11;8:27. doi: 10.1186/1476-4598-8-27.

13.

Global transcriptional profiling reveals Streptococcus agalactiae genes controlled by the MtaR transcription factor.

Bryan JD, Liles R, Cvek U, Trutschl M, Shelver D.

BMC Genomics. 2008 Dec 16;9:607. doi: 10.1186/1471-2164-9-607.

14.

Retinoids and skin: microarrays shed new light on chemopreventive action of all-trans retinoic acid.

Cheepala SB, Syed Z, Trutschl M, Cvek U, Clifford JL.

Mol Carcinog. 2007 Aug;46(8):634-9. Review.

PMID:
17538947
15.

Translation initiation factor eIF4G-1 binds to eIF3 through the eIF3e subunit.

LeFebvre AK, Korneeva NL, Trutschl M, Cvek U, Duzan RD, Bradley CA, Hershey JW, Rhoads RE.

J Biol Chem. 2006 Aug 11;281(32):22917-32. Epub 2006 Jun 9.

Supplemental Content

Support Center